Tanya R. Myers

4.2k citations

48 papers · 2.0k · 3 hit papers · h-index 22

Impact in

Health top 1%
- Vaccine Coverage and Hesitancy
Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies

Papers in

Infectious Diseases 29
- SARS-CoV-2 and COVID-19 Research 26
Health 22
- Vaccine Coverage and Hesitancy 22

Co-authors: Julianne Gee (24 shared papers)Paige Marquez (26 shared papers)Tom T. Shimabukuro (22 shared papers)John R. Su (17 shared papers)David K. Shay (24 shared papers)Johanna Chapin-Bardales (2 shared papers)Anne M. Hause (20 shared papers)Bicheng Zhang (15 shared papers)
Journals: MMWR Morbidity and Mortality Weekly Report (16 papers)Vaccine (6 papers)JAMA Network Open (3 papers)Human Vaccines & Immunotherapeutics (3 papers)Emerging infectious diseases (2 papers)
Partner nations: United States United Kingdom Ireland

In The Last Decade

Tanya R. Myers

48 papers receiving 1.9k citations

Tanya R. Myers's Hit Papers

align trajectories log scale

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe 2022 · 116 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 The Lancet Infectious Diseases
2021 MMWR Morbidity and Mortality Weekly Report
2021 JAMA

Peers

Countries citing papers authored by Tanya R. Myers

Since Specialization

Citations

This map shows the geographic impact of Tanya R. Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya R. Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya R. Myers more than expected).

Fields of papers citing papers by Tanya R. Myers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya R. Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya R. Myers. The network helps show where Tanya R. Myers may publish in the future.

Co-authors

The 25 scholars most cited alongside Tanya R. Myers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tanya R. Myers Line = papers co-authored together Tanya R. Myers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 MMWR Morbidity and Mortality Weekly Report ·Julianne Gee, Paige Marquez, John R. Su, Geoffrey M. Calvert, Ruiling Liu, Tanya R. Myers, Narayan Nair, Stacey W. Martin, Thomas A. Clark, Lauri E. Markowitz, Nicole P. Lindsey, Bicheng Zhang, Charles Licata, Amelia Jazwa, Mark J. Sotir, Tom T. Shimabukuro Hit paper breakdown →	2021	275
2	Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines JAMA ·Johanna Chapin-Bardales, Julianne Gee, Tanya R. Myers Hit paper breakdown →	2021	229
3	Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 MMWR Morbidity and Mortality Weekly Report ·David K. Shay, Julianne Gee, John R. Su, Tanya R. Myers, Paige Marquez, Ruiling Liu, Bicheng Zhang, Charles Licata, Thomas A. Clark, Tom T. Shimabukuro	2021	120
4	COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, James Baggs, Paige Marquez, Tanya R. Myers, Julianne Gee, John R. Su, Bicheng Zhang, Deborah Thompson, Tom T. Shimabukuro, David K. Shay	2021	119
5	Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe The Lancet Infectious Diseases ·Hannah G. Rosenblum, Julianne Gee, Ruiling Liu, Paige Marquez, Bicheng Zhang, Penelope Strid, Winston E. Abara, Michael M. McNeil, Tanya R. Myers, Anne M. Hause, John R. Su, Lauri E. Markowitz, Tom T. Shimabukuro, David K. Shay Hit paper breakdown →	2022	116
6	COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, Julianne Gee, James Baggs, Winston E. Abara, Paige Marquez, Deborah Thompson, John R. Su, Charles Licata, Hannah G. Rosenblum, Tanya R. Myers, Tom T. Shimabukuro, David K. Shay	2021	111
7	SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers, March 1–May 30, 2020 MMWR Morbidity and Mortality Weekly Report ·Lakshmi Panagiotakopoulos, Tanya R. Myers, Julianne Gee, Heather S. Lipkind, Elyse O. Kharbanda, Denison S Ryan, Joshua T.B. Williams, Allison L. Naleway, Nicola P. Klein, Simon J. Hambidge, Steven J. Jacobsen, Jason M. Glanz, Lisa A. Jackson, Tom T. Shimabukuro, Eric Weintraub	2020	107
8	Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink JAMA Network Open ·Kayla E. Hanson, Kristin Goddard, Ned Lewis, Bruce Fireman, Tanya R. Myers, Nandini Bakshi, Eric Weintraub, James G. Donahue, Jennifer C. Nelson, Stan Xu, Jason M. Glanz, Joshua T.B. Williams, Jonathan D. Alpern, Nicola P. Klein	2022	98
9	Toxaphene in Great Lakes Fish: A Temporal, Spatial, and Trophic Study Environmental Science & Technology ·Susan T. Glassmeyer, David S. De Vault, Tanya R. Myers, Ronald A. Hites	1996	66
10	Surveillance of Zoonotic Infectious Disease Transmitted by Small Companion Animals Emerging infectious diseases ·Michael Day, Edward B. Breitschwerdt, Sarah Cleaveland, Umesh Karkare, Chand Khanna, Jolle Kirpensteijn, Thijs Kuiken, Michael R. Lappin, Jennifer H. McQuiston, Elizabeth Mumford, Tanya R. Myers, M Palatnik, Carol Rubin, Gregg Takashima, A. B. Thiermann	2012	64
11	Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, James Baggs, Paige Marquez, Tanya R. Myers, John R. Su, Phillip G. Blanc, Jane Baumblatt, Emily Jane Woo, Julianne Gee, Tom T. Shimabukuro, David K. Shay	2022	61
12	Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, James Baggs, Julianne Gee, Paige Marquez, Tanya R. Myers, Tom T. Shimabukuro, David K. Shay	2021	57
13	Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, Paige Marquez, Bicheng Zhang, Tanya R. Myers, Julianne Gee, John R. Su, Phillip G. Blanc, Alisha Thomas, Deborah Thompson, Tom T. Shimabukuro, David K. Shay	2022	50
14	Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States JAMA Network Open ·Winston E. Abara, Julianne Gee, Paige Marquez, Jared Woo, Tanya R. Myers, Allison DeSantis, Jane Baumblatt, Emily Jane Woo, Deborah Thompson, Narayan Nair, John R. Su, Tom T. Shimabukuro, David K. Shay	2023	41
15	COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, Paige Marquez, Bicheng Zhang, Tanya R. Myers, Julianne Gee, John R. Su, Casey Parker, Deborah Thompson, S. Panchanathan, Tom T. Shimabukuro, David K. Shay	2022	40
16	Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study The Lancet Digital Health ·Karen K. Wong, Charles M. Heilig, Anne M. Hause, Tanya R. Myers, Christine K. Olson, Julianne Gee, Paige Marquez, Penelope Strid, David K. Shay	2022	38
17	Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, James Baggs, Paige Marquez, Winston E. Abara, Babatunde Olubajo, Tanya R. Myers, John R. Su, Deborah Thompson, Julianne Gee, Tom T. Shimabukuro, David K. Shay	2022	34
18	Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US JAMA Network Open ·Anne M. Hause, Bicheng Zhang, Xin Yue, Paige Marquez, Tanya R. Myers, Casey Parker, Julianne Gee, John R. Su, Tom T. Shimabukuro, David K. Shay	2022	27
19	Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, Paige Marquez, Bicheng Zhang, John R. Su, Tanya R. Myers, Julianne Gee, S. Panchanathan, Deborah Thompson, Tom T. Shimabukuro, David K. Shay	2023	23
20	Review of Institute of Medicine and National Research Council Recommendations for One Health Initiative Emerging infectious diseases ·Carol Rubin, Tanya R. Myers, William Stokes, Bernadette Dunham, Stic Harris, Beth Lautner, Joseph Annelli	2013	23

About Tanya R. Myers

Tanya R. Myers is a scholar working on Infectious Diseases, Health, Cardiology and Cardiovascular Medicine, Epidemiology and Neurology, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (26 papers), Vaccine Coverage and Hesitancy (22 papers), Viral Infections and Immunology Research (8 papers), Peripheral Neuropathies and Disorders (7 papers), COVID-19 Impact on Reproduction (5 papers), Bacterial Infections and Vaccines (5 papers), Pharmaceutical studies and practices (3 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Health (678 citations), Infectious Diseases (1.2k citations), Obstetrics and Gynecology (284 citations), Modeling and Simulation (114 citations) and Neurology (201 citations). Tanya R. Myers has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Julianne Gee, Paige Marquez, Tom T. Shimabukuro, John R. Su, David K. Shay, Johanna Chapin-Bardales, Anne M. Hause, Bicheng Zhang, James Baggs and Deborah Thompson. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Vaccine, JAMA Network Open, Human Vaccines & Immunotherapeutics and Emerging infectious diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Tanya R. Myers

Impact in

Papers in i

In The Last Decade

Tanya R. Myers

Tanya R. Myers's Hit Papers

Peers

Countries citing papers authored by Tanya R. Myers

Fields of papers citing papers by Tanya R. Myers

All Works

About Tanya R. Myers

Explore authors with similar magnitude of impact

Papers in